Delivery Order SPE2DB25D3201-SPE2DB25FNUNT
Award Date 7/8/25
Potential Completion Date 7/9/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,086.04, is for the delivery of GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 18, 2024. There is no set-aside designation indicated for this contract. AmerisourceBergen Drug Corp...
- This federal contract award, valued at $1,704.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,175,077 units of GADAVIST 1 MMOL/ML BULK VIAL 30ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2025. It is not designated as a set-aside contract, indicating open competition....
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GADAVIST 10 MMOL/10 ML SYRINGE 10ML. The contract has a ceiling value of $1,246.14 and a period of performance through October 17, 2024. It is a Firm Fixed Price contract, indicating a predetermined unit cost for the products. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Gadavist 1 mmol/ml bulk vials (30 ml). The order has a ceiling value of $1,711.35 and is a firm fixed price contract with a completion date of July 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of...
- This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GADAVIST, a medical imaging agent, with a ceiling value of $3,233.04. It is a firm fixed price contract without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that is valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Gadavist 10 mmol/10 ml vials. The contract has a firm fixed price of $2,194.40 and a completion date of August 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gadavist 1 mmol/ml bulk vials (30 ml). The contract has a firm fixed price of $1,704.90 and an ultimate completion date of March 28, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.20 firm fixed-price delivery order is for the medical product "GADAVIST 10 MMOL/10 ML VIAL 10ML" and has a completion date of June 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,083.96, is for the delivery of Gadavist 7.5 millimolar/7.5 milliliter vials. It is a firm fixed-price contract with a period of performance ending on May 5, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Gadavist, a pharmaceutical product, with a ceiling value of $1,062.40 and an ultimate completion date of January 21, 2025. The contract is a firm-fixed-price delivery order, which is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...